Overview

Assessment of Alcon's Ocular Image Quantification System

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate ocular responses with different allergen provocation methods.
Phase:
Phase 4
Details
Lead Sponsor:
Alcon Research
Treatments:
Dextrans
Olopatadine Hydrochloride
Ophthalmic Solutions